Prognostic Superiority of the White Cell-to-Lymphocyte Ratio (WLR) in Predicting Overall Survival in Patients With Gliomas
In Vivo · 2026
DOI: 10.21873/invivo.14271 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Xiao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China. Hauptthemen laut MEDLINE: Glioma, Lymphocytes, Leukocytes, Brain Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China.
- Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China zhangheyang@mail.ccmu.edu.cn.
- Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China; yongbozhang@ccmu.edu.cn.
Zitieren
APA
Zhang, X., Cai, G., Zhang, H., & Zhang, Y. (2026). Prognostic Superiority of the White Cell-to-Lymphocyte Ratio (WLR) in Predicting Overall Survival in Patients With Gliomas. In Vivo. https://doi.org/10.21873/invivo.14271
Vancouver
Zhang X, Cai G, Zhang H, Zhang Y. Prognostic Superiority of the White Cell-to-Lymphocyte Ratio (WLR) in Predicting Overall Survival in Patients With Gliomas. In Vivo. 2026. doi:10.21873/invivo.14271
BibTeX
@article{Zhang2026,
author = {Zhang, Xiao and Cai, Guilan and Zhang, Heyang and Zhang, Yongbo},
title = {Prognostic Superiority of the White Cell-to-Lymphocyte Ratio (WLR) in Predicting Overall Survival in Patients With Gliomas},
journal = {In Vivo},
year = {2026},
doi = {10.21873/invivo.14271}
}
EUVIMED